WILHEMINA BOABENG OFFEI

RESPONSIBILITIES & ACHIEVEMENTS

• Developed the early-phase implementation strategy for the recruitment site.
• Developed the two-phased training plan for the clinical stakeholders on the project.
• Designed the site SOP and manual for clinical activities.
• Developed the monthly site budget.
• Coordinated weekly screening activities and daily patient monitoring.
• Successful execution of a 750-sample-size clinical study.

RESEARCH PROJECTS

• Designing a three-staged implementation roadmap for pharmacogenetic testing into clinical pathways: August 2025
• Evaluation of recurrent malaria after treatment with artemisinin-based combination therapies of uncomplicated or severe cases among children 10 years and younger in Ghana (SMART & SELF-TX): May-August 2024.
• Clinical assessment of the effect of near point-of-care diagnostic strategy in patients with Acute respiratory infections for guiding adequate therapy in a malaria endemic(CLAARITY): 2023-2024
• COVID-like illness; respiratory pathogens-diagnostics response in Ghana: A prospective cohort on the COVID-19 post-acute condition (CLEAR): 2022-2023.
• Phase III non-inferiority trial: AntimalarialS tri-therapy with Atovaquone-Proguanil for treatment of uncomplicated Malaria in African Children (ASAAP): 2022-2024.

TRAININGS & WORKSHOPS

• KSOM Leadership Training (2026).
• Clinical Trial Stakeholders Training- Food & Drugs Authority (FDA) (2024).
• Radiological Imaging Training: Procedure & Interpretation(2024).
• Addressing Data Science Challenges for AI in Health (2023).
• Clinical Research for Study Coordinators (2023).
• FDA- Good Clinical Practice (ICH-GCP) (2022).